PAPER Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, Tremont G,
SEARCH RESULTS
330907 RESULTS
PAPER Whitehair DC, Sherzai A, Emond J, Raman R, Aisen PS, Petersen RC, Fleisher AS,
Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
Alzheimers Dement. 2010 Sep;6(5):412-9. PubMed: 20813342PAPER Iqbal K, Grundke-Iqbal I
Alzheimer's disease, a multifactorial disorder seeking multitherapies.
Alzheimers Dement. 2010 Sep;6(5):420-4. PubMed: 20813343PAPER Granic I, Masman MF, Luiten PG, Eisel UL
Braak staging in mouse models of Alzheimer's disease.
Am J Pathol. 2010 Oct;177(4):1603-5. PubMed: 20813967PAPER Ranjith N, Mathuranath PS, Sharma G, Alexander A
Qualitative aspects of learning, recall, and recognition in dementia.
Ann Indian Acad Neurol. 2010 Apr;13(2):117-22. PubMed: 20814495PAPER Ichimura Y, Komatsu M
Selective degradation of p62 by autophagy.
Semin Immunopathol. 2010 Dec;32(4):431-6. PubMed: 20814791PAPER Qiu C, Fratiglioni L
Apolipoprotein E epsilon4 status and cognitive decline with and without dementia.
Arch Neurol. 2010 Aug;67(8):1036. PubMed: 20697064PAPER Geda YE
A purpose-oriented life: is it potentially neuroprotective?
Arch Neurol. 2010 Aug;67(8):1010-1. PubMed: 20697053PAPER Callard F, Lovestone S, Pritchard M
Giving dementia a voice.
Ment Health Today. 2010 Jul-Aug;:34-5. PubMed: 20700944PAPER Mei X, Ezan P, Giaume C, Koulakoff A
Astroglial connexin immunoreactivity is specifically altered at β-amyloid plaques in β-amyloid precursor protein/presenilin1 mice.
Neuroscience. 2010 Nov 24;171(1):92-105. PubMed: 20813165PAPER Zabel C, Nguyen HP, Hin SC, Hartl D, Mao L, Klose J
Proteasome and oxidative phoshorylation changes may explain why aging is a risk factor for neurodegenerative disorders.
J Proteomics. 2010 Oct 10;73(11):2230-8. PubMed: 20813214PAPER Schneider LS, Kennedy RE, Cutter GR,
Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.
Alzheimers Dement. 2010 Sep;6(5):367-77. PubMed: 20813339PAPER Kobayashi Z, Tsuchiya K, Arai T, Yokota O, Yoshida M, Shimomura Y, Kondo H, Haga C, Asaoka T, Onaya M, Ishizu H, Akiyama H, Mizusawa H
Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss.
J Neurol Sci. 2010 Nov 15;298(1-2):70-7. PubMed: 20810131PAPER Clark J, Clore EL, Zheng K, Adame A, Masliah E, Simon DK
Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice.
PLoS One. 2010;5(8):e12333. PubMed: 20808797PAPER Takadera T, Koriyama Y, Kimura T, Kato S
5-S-GAD attenuates Fe²+-induced lipid peroxidation and cell death in a neuronal cell model.
Neurotox Res. 2011 Jul;20(1):26-31. PubMed: 20809179Current Filters
No filters selected